Association of Metformin Treatment with Risk for Death in Diabetic Patients with Concomitant Gastric Cancer

SIMPLE SUMMARY: During the 5-year follow-up within the study period, the cumulative incidence of all-cause death was notably lower in the metformin treatment group compared to the non-treatment group (27.5% vs. 32.8%). The analysis further revealed a significantly reduced hazard ratio (HR) for all-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Joo, Jae-Hong, Zhang, Hyun-Soo, Chun, Jiyeon, Park, Eun-Cheol, Park, Sohee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452498/
https://www.ncbi.nlm.nih.gov/pubmed/37627162
http://dx.doi.org/10.3390/cancers15164134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452498/
https://www.ncbi.nlm.nih.gov/pubmed/37627162
http://dx.doi.org/10.3390/cancers15164134

Ejemplares similares